Advances of Precision Medicine in Oncology

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".

Deadline for manuscript submissions: 25 June 2024 | Viewed by 176

Special Issue Editors


E-Mail Website
Guest Editor
1. School of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK
2. National Horizons Centre, Teesside University, Darlington DL1 1HG, UK
Interests: extracellular proteolysis; proteolytic enzymes; tumor microenvironment; cytokines; chemotherapy; clinical biomarkers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Medical School, University of Cyprus, Nicosia 1678, Cyprus
2. Bank of Cyprus Oncology Centre, Strovolos 2011, Cyprus
3. Cyprus Cancer Research Institute (CCRI), Nicosia 2116, Cyprus
Interests: targeted therapy; translational research; cancer biomarkers; medical oncology

Special Issue Information

Dear Colleagues,

Precision medicine is an emerging medical field, representing the future for individual diagnostics and therapeutic interventions. Targeted to the molecular basis of cancer, precision oncology uses individual differences to create personalized treatment plans. Consequently, it is of significance to develop a deeper understanding of molecular portraits and advance personalized diagnostics and therapeutic interventions accordingly.

This Special Issue focuses on the identification and elucidation of the role of novel biomolecules implicated in cancer progression and the tumor- and metastasis-promoting microenvironment, their clinical applications as cancer biomarkers and the development of novel personalized treatments.

We welcome authors to submit original research and reviews on malignancies. Submissions should focus on (but are not limited to) the following areas:

  • Emerging technologies for cancer biomarker discovery.
  • Identification of novel proteins and other biomolecules as cancer biomarkers in diagnostics and the tumour pathways for therapeutics.
  • Molecular diagnostic approaches and bioinformatics to guide cancer diagnosis and treatment.
  • Clinical applications in precision cancer medicine.
  • Circulating tumor cells and circulating tumor DNA in liquid biopsies.

Dr. Panagiota Filippou
Dr. Anastasia Constantinidou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • precision medicine
  • personalized cancer care
  • circulating tumor cells
  • biomolecules
  • liquid biopsies
  • omics technologies
  • biomarkers

Published Papers

This special issue is now open for submission.
Back to TopTop